Recent changes
Track the most recent changes to the wiki on this page.
10 December 2018
| 00:10 | Immunodeficiency affecting cellular and humoral Immunity (diff | hist) . . (+475) . . Syed Musadiq Ali (talk | contribs) (→T-cell Receptor Alpha Deficiency) |
9 December 2018
| 23:52 | Immunodeficiency affecting cellular and humoral Immunity (18 changes | history) . . (+2,340) . . [Syed Musadiq Ali (18×)] | ||
| 23:52 (cur | prev) . . (+261) . . Syed Musadiq Ali (talk | contribs) (→RHOH Deficiency) | |||
| 23:37 (cur | prev) . . (+639) . . Syed Musadiq Ali (talk | contribs) (→CARD11 Deficiency) | |||
| 23:08 (cur | prev) . . (+369) . . Syed Musadiq Ali (talk | contribs) (→Macrophage Stimulating 1 Deficiency) | |||
| 22:57 (cur | prev) . . (+471) . . Syed Musadiq Ali (talk | contribs) (→NF-κB inducing kinase Deficiency) | |||
| 22:49 (cur | prev) . . (+453) . . Syed Musadiq Ali (talk | contribs) (→Interleukin 21 Deficiency) | |||
| 22:38 (cur | prev) . . (+9) . . Syed Musadiq Ali (talk | contribs) (→CD8 Deficiency) | |||
| 22:37 (cur | prev) . . (-1) . . Syed Musadiq Ali (talk | contribs) (→Major Histocompatibility Complex II Deficiency) | |||
| 22:35 (cur | prev) . . (0) . . Syed Musadiq Ali (talk | contribs) (→Major Histocompatibility Complex 1 Deficiency) | |||
| 22:34 (cur | prev) . . (0) . . Syed Musadiq Ali (talk | contribs) (→Zeta-Chain-Associated Protein Kinase 70 (ZAP70) Deficiency) | |||
| 22:33 (cur | prev) . . (+1) . . Syed Musadiq Ali (talk | contribs) (→CD8 Deficiency) | |||
| 22:30 (cur | prev) . . (+26) . . Syed Musadiq Ali (talk | contribs) (→RHOH Deficiency) | |||
| 22:28 (cur | prev) . . (0) . . Syed Musadiq Ali (talk | contribs) (→CD3Y Deficiency) | |||
| 22:23 (cur | prev) . . (+1) . . Syed Musadiq Ali (talk | contribs) (→Moesin Deficiency) | |||
| 22:22 (cur | prev) . . (+20) . . Syed Musadiq Ali (talk | contribs) (→NIK Deficiency) | |||
| 22:20 (cur | prev) . . (+11) . . Syed Musadiq Ali (talk | contribs) (→IL21 Deficiency) | |||
| 22:18 (cur | prev) . . (+1) . . Syed Musadiq Ali (talk | contribs) (→Macrophage Stimulating 1 Deficiency) | |||
| 22:17 (cur | prev) . . (+49) . . Syed Musadiq Ali (talk | contribs) (→MST1 Deficiency) | |||
| 22:14 (cur | prev) . . (+30) . . Syed Musadiq Ali (talk | contribs) (→MHC1 Deficiency) |
| 17:24 | Hereditary spherocytosis overview (19 changes | history) . . (-835) . . [Zahir Ali Shaikh (19×)] | ||
| 17:24 (cur | prev) . . (+61) . . Zahir Ali Shaikh (talk | contribs) (→Prevention) | |||
| 17:22 (cur | prev) . . (+541) . . Zahir Ali Shaikh (talk | contribs) (→Surgery) | |||
| 17:20 (cur | prev) . . (+87) . . Zahir Ali Shaikh (talk | contribs) (→Medical Therapy) | |||
| 17:17 (cur | prev) . . (0) . . Zahir Ali Shaikh (talk | contribs) (→Other Diagnostic Studies:) | |||
| 17:17 (cur | prev) . . (+84) . . Zahir Ali Shaikh (talk | contribs) (→Other Diagnostic Studies:) | |||
| 17:16 (cur | prev) . . (+105) . . Zahir Ali Shaikh (talk | contribs) (→Imaging Findings:) | |||
| 17:10 (cur | prev) . . (+811) . . Zahir Ali Shaikh (talk | contribs) (→Laboratory Findings) | |||
| 17:09 (cur | prev) . . (+301) . . Zahir Ali Shaikh (talk | contribs) (→Physical Examination) | |||
| 17:07 (cur | prev) . . (+774) . . Zahir Ali Shaikh (talk | contribs) (→History and Symptoms) | |||
| 17:06 (cur | prev) . . (-3,336) . . Zahir Ali Shaikh (talk | contribs) (→Diagnosis) | |||
| 17:02 (cur | prev) . . (-2,524) . . Zahir Ali Shaikh (talk | contribs) (→Natural History, Complications, and Prognosis) | |||
| 17:01 (cur | prev) . . (+590) . . Zahir Ali Shaikh (talk | contribs) (→Screening) | |||
| 16:59 (cur | prev) . . (-122) . . Zahir Ali Shaikh (talk | contribs) (→Risk Factors) | |||
| 16:58 (cur | prev) . . (+295) . . Zahir Ali Shaikh (talk | contribs) (→Epidemiology and Demographics) | |||
| 16:56 (cur | prev) . . (-91) . . Zahir Ali Shaikh (talk | contribs) (→Differentiating {{PAGENAME}} from Other Diseases) | |||
| 16:55 (cur | prev) . . (-6) . . Zahir Ali Shaikh (talk | contribs) (→Causes) | |||
| 16:53 (cur | prev) . . (+1,253) . . Zahir Ali Shaikh (talk | contribs) (→Pathophysiology) | |||
| 16:51 (cur | prev) . . (+265) . . Zahir Ali Shaikh (talk | contribs) (→Classification) | |||
| 16:50 (cur | prev) . . (+77) . . Zahir Ali Shaikh (talk | contribs) (→Historical Perspective) |
| 17:02 | Leadership (3 changes | history) . . (+5,079) . . [Badgettrg (3×)] | ||
| 17:02 (cur | prev) . . (+612) . . Badgettrg (talk | contribs) (→High-Performance Work Practices (HPWP)) | |||
| 16:52 (cur | prev) . . (+2,095) . . Badgettrg (talk | contribs) (→High-Performance Work Practices (HPWP)) | |||
| 16:38 (cur | prev) . . (+2,372) . . Badgettrg (talk | contribs) (→Evidence-based management: Started HPWP) |
| 00:28 | Cardiomyopathy primary prevention (diff | hist) . . (+156) . . Lina Yaqoub (talk | contribs) (→Overview) (Tag: Visual edit) |
| 00:24 | Cardiomyopathy (diff | hist) . . (-11,576) . . Lina Yaqoub (talk | contribs) (→Historical Perspective) (Tag: Visual edit) |
| 00:14 | Cardiomyopathy medical therapy (diff | hist) . . (+242) . . Lina Yaqoub (talk | contribs) (→ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death - Infiltrative Cardiomyopathies (DO NOT EDIT) [1]) (Tag: Visual edit) |
8 December 2018
| 23:57 | Cardiomyopathy historical perspective (diff | hist) . . (+3,074) . . Lina Yaqoub (talk | contribs) (→References) |
| 23:22 | Selective immunoglobulin A deficiency (5 changes | history) . . (+142) . . [Muhammad Affan (5×)] | ||
| 23:22 (cur | prev) . . (-8) . . Muhammad Affan (talk | contribs) (→Associated Conditions) | |||
| 22:50 (cur | prev) . . (+16) . . Muhammad Affan (talk | contribs) (→Epidemiology and Demographics) | |||
| 22:48 (cur | prev) . . (+10) . . Muhammad Affan (talk | contribs) (→Risk Factors) | |||
| 22:45 (cur | prev) . . (+46) . . Muhammad Affan (talk | contribs) (→Natural History, Complications, and Prognosis) | |||
| 22:40 (cur | prev) . . (+78) . . Muhammad Affan (talk | contribs) (→Diagnostic Criteria) |
